Drug carrier for photodynamic cancer therapy

International Journal of Molecular Sciences

Volumn 16, Issue 9, 2015, Pages 22094-22136

  Debele, Tilahun Ayane ^a   Peng, Sydney ^b   Tsai, Hsieh Chih ^a  

^a NATIONAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

Biodegradable; Cancer cells; Inorganic nanocarrier; Nanoparticles; Organic nanocarrier; Photodynamic therapy; Photosensitizers

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ALBUMIN; CALCIUM ION; CHITOSAN; DENDRIMER; DRUG CARRIER; HYALURONIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; LIPOSOME; NANOPARTICLE; OXYGEN; PHOTOSENSITIZING AGENT; PROTEIN P53; QUANTUM DOT; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BLOOD VESSEL INJURY; CANCER THERAPY; CELL DEATH; CLINICAL TRIAL (TOPIC); ENERGY TRANSFER; HUMAN; IMMUNE RESPONSE; INFLAMMATION; NECROSIS; NONHUMAN; PHOTODYNAMIC THERAPY; REVIEW; TUMOR CELL; ANIMAL; CHEMISTRY; NEOPLASMS; PHOTOCHEMOTHERAPY; PROCEDURES;

ANIMALS; DRUG CARRIERS; HUMANS; NANOPARTICLES; NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS;

EID: 84941627541     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms160922094     Document Type: Review

References (314)

1. Komerik, N.; Wilson, M.; Poole, S. The effect of photodynamic action on two virulence factors of gram-negative bacteria. Photochem. Photobiol. 2000, 72, 676-680.
2. Rajesh, S.; Koshi, E.; Philip, K.; Mohan, A. Antimicrobial photodynamic therapy: An overview. J. Indian Soc. Periodontol. 2011, 15, 323-327.
3. Ackroyd, R.; Kelty, C.; Brown, N.; Reed, M. The history of photodetection and photodynamic therapy. Photochem. Photobiol. 2001, 74, 656-669.
4. Yoon, I.; Li, J.Z.; Shim, Y.K. Advance in photosensitizers and light delivery for photodynamic therapy. Clin. Endosc. 2013, 46, 7-23.
5. Maisch, T.; Szeimies, R.M.; Jori, G.; Abels, C. Antibacterial photodynamic therapy in dermatology. Photochem. Photobiol. Sci. 2004, 3, 907-917.
6. Castano, A.P.; Demidova, T.N.; Hamblin, M.R. Mechanisms in photodynamic therapy: Part one—Photosensitizers, photochemistry and cellular localization. Photodiagn. Photodyn. Ther. 2004, 1, 279-293.
7. Ma, J.; Jiang, L. Photogeneration of singlet oxygen (1O2) and free radicals (Sen−, O−2) by tetra-brominated hypocrellin B derivative. Free Radic. Res. 2001, 35, 767-777.
8. Staicu, A.; Pascu, A.; Nuta, A.; Sorescu, A.; Raditoiu, V.; Pascu, M. Studies about phthalocyanine photosensitizers to be used in photodynamic therapy. Rom. Rep. Phys. 2013, 65, 1032-1051.
9. Zhao, B.; He, Y.Y. Recent advances in the prevention and treatment of skin cancer using photodynamic therapy. Expert Rev. Anticancer Ther. 2010, 10, 1797-809.
10. MacCormack, M.A. Photodynamic therapy in dermatology: An update on applications and outcomes. Semin. Cutan. Med. Surg. 2008, 27, 52-62.
11. Abels, C. Targeting of the vascular system of solid tumours by photodynamic therapy (PDT). Photochem. Photobiol. Sci. 2004, 3, 765-771.
12. Castano, A.P.; Mroz, P.; Hamblin, M.R. Photodynamic therapy and anti-tumour immunity. Nat. Rev. Cancer 2006, 6, 535-545.
13. Mroz, P.; Yaroslavsky, A.; Kharkwal, G.B.; Hamblin, M.R. Cell death pathways in photodynamic therapy of cancer. Cancers 2011, 3, 2516-2539.
14. Nowis, D.; Makowski, M.; Stoklosa, T.; Legat, M.; Issat, T.; Golab, J. Direct tumor damage mechanisms of photodynamic therapy. Acta Biochim. Pol. 2005, 52, 339-352.
15. Castano, A.P.; Demidova, T.N.; Hamblin, M.R. Mechanisms in photodynamic therapy: Part three—Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction. Photodiagn. Photodyn. Ther. 2005, 2, 91-106.
16. Kroemer, G.; Galluzzi, L.; Vandenabeele, P.; Abrams, J.; Alnemri, E.S.; Baehrecke, E.H.; Blagosklonny, M.V.; El-Deiry, W.S.; Golstein, P.; Green, D.R.; et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ. 2009, 16, 3-11.
17. Soriano, J.; Villanueva, A.; Stockert, J.C.; Canete, M. Regulated necrosis in HeLa cells induced by ZnPc photodynamic treatment: A new nuclear morphology. Int. J. Mol. Sci. 2014, 15, 22772-22785.
18. Zong, W.X.; Thompson, C.B. Necrotic death as a cell fate. Genes Dev. 2006, 20, 1-15.
19. Oleinick, N.L.; Morris, R.L.; Belichenko, I. The role of apoptosis in response to photodynamic therapy: What, where, why, and how. Photochem. Photobiol. Sci. 2002, 1, 1-21.
20. Kessel, D.; Vicente, M.G.; Reiners, J.J. Initiation of apoptosis and autophagy by photodynamic therapy. Lasers Surg. Med. 2006, 38, 482-488.
21. Golstein, P.; Kroemer, G. Cell death by necrosis: Towards a molecular definition. Trends Biochem. Sci. 2007, 32, 37-43.
22. Reiners, J.J.; Caruso, J.A.; Mathieu, P.; Chelladurai, B.; Yin, X.M.; Kessel, D. Release of cytochrome c and activation of pro-caspase-9 following lysosomal photodamage involves Bid cleavage. Cell Death Differ. 2002, 9, 934-944.
23. Almeida, R.D.; Manadas, B.J.; Carvalho, A.P.; Duarte, C.B. Intracellular signaling mechanisms in photodynamic therapy. BBA Gen. Subj. 2004, 1704, 59-86.
24. Bittremieux, M.; Bultynck, G. P53 and Ca2+ signaling from the endoplasmic reticulum: Partners in anti-cancer therapies. Oncoscience 2015, 2, 233-238.
25. Acedo, P.; Zawacka-Pankau, J. P53 family members—Important messengers in cell death signaling in photodynamic therapy of cancer? Photochem. Photobiol. Sci. 2015, 14, 1390-1396.
26. Giorgi, C.; Bonora, M.; Missiroli, S.; Poletti, F.; Ramirez, F.G.; Morciano, G.; Morganti, C.; Pandolfi, P.P.; Mammano, F.; Pinton, P. Intravital imaging reveals p53-dependent cancer cell death induced by phototherapy via calcium signaling. Oncotarget 2015, 6, 1435-1445.
27. Nishida, N.; Yano, H.; Nishida, T.; Kamura, T.; Kojiro, M. Angiogenesis in Cancer. Vasc. Health Risk Manag. 2006, 2, 213-219.
28. Bhuvaneswari, R.; Gan, Y.Y.; Soo, K.C.; Olivo, M. The effect of photodynamic therapy on tumor angiogenesis. Cell. Mol. Life Sci. 2009, 66, 2275-2283.
29. Fingar, V.H.; Wieman, T.J.; Wiehle, S.A.; Cerrito, P.B. The role of microvascular damage in photodynamic therapy: The effect of treatment on vessel constriction, permeability, and leukocyte adhesion. Cancer Res. 1992, 52, 4914-4921.
30. Kerdel, F.A.; Soter, N.A.; Lim, H.W. In vivo mediator release and degranulation of mast cells in hematoporphyrin derivative-induced phototoxicity in mice. J. Investig. Dermatol. 1987, 88, 277-280.
31. Henderson, B.W.; Fingar, V.H. Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. Cancer Res. 1987, 47, 3110-3114.
32. Chen, B.; Pogue, B.W.; Luna, J.M.; Hardman, R.L.; Hoopes, P.J.; Hasan, T. Tumor vascular permeabilization by vascular-targeting photosensitization: Effects, mechanism, and therapeutic implications. Clin. Cancer Res. 2006, 12, 917-923.
33. Milla Sanabria, L.; Rodriguez, M.E.; Cogno, I.S.; Rumie Vittar, N.B.; Pansa, M.F.; Lamberti, M.J.; Rivarola, V.A. Direct and indirect photodynamic therapy effects on the cellular and molecular components of the tumor microenvironment. BBA-Res. Cancer 2013, 1835, 36-45.
34. Mroz, P.; Hashmi, J.T.; Huang, Y.Y.; Lange, N.; Hamblin, M.R. Stimulation of anti-tumor immunity by photodynamic therapy. Expert Rev. Clin. Immunol. 2011, 7, 75-91.
35. Cecic, I.; Korbelik, M. Mediators of peripheral blood neutrophilia induced by photodynamic therapy of solid tumors. Cancer Lett. 2002, 183, 43-51.
36. Korbelik, M.; Cecic, I. Complement activation cascade and its regulation: Relevance for the response of solid tumors to photodynamic therapy. J. Photochem. Photobiol. B Biol. 2008, 93, 53-59.
37. Korbelik, M.; Dougherty, G.J. Photodynamic therapy-mediated immune response against subcutaneous mouse tumors. Cancer Res. 1999, 59, 1941-1946.
38. Li, F.; Cheng, Y.; Lu, J.; Hu, R.; Wan, Q.; Feng, H. Photodynamic therapy boosts anti-glioma immunity in mice: A dependence on the activities of T cells and complement C 3. J. Cell. Biochem. 2011, 112, 3035-3043.
39. Allison, R.R.; Moghissi, K. Photodynamic Therapy (PDT): PDT Mechanisms. Clin. Endosc. 2013, 46, 24-29.
40. Moan, J. Properties for optimal PDT sensitizers. J. Photochem. Photobiol. B Biol. 1990, 5, 521-524.
41. Ormond, A.; Freeman, H. Dye Sensitizers for Photodynamic Therapy. Materials 2013, 6, 817-840.
42. Sternberg, E.D.; Dolphin, D.; Brückner, C. Porphyrin-based photosensitizers for use in photodynamic therapy. Tetrahedron 1998, 54, 4151-4202.
43. Schuitmaker, J.J.; Baas, P.; van Leengoed, H.L.; van der Meulen, F.W.; Star, W.M.; van Zandwijk, N. Photodynamic therapy: A promising new modality for the treatment of cancer. J. Photochem. Photobiol. B Biol. 1996, 34, 3-12.
44. Stylli, S.S.; Kaye, A.H.; MacGregor, L.; Howes, M.; Rajendra, P. Photodynamic therapy of high grade glioma—Long Term survival. J. Clin. Neurosci. 2005, 12, 389-398.
45. Pushpan, S.K.; Venkatraman, S.; Anand, V.G.; Sankar, J.; Parmeswaran, D.; Ganesan, S.; Chandrashekar, T.K. Porphyrins in photodynamic therapy—A search for ideal photosensitizers. Curr. Med. Chem. Anti-Cancer Agent. 2002, 2, 187-207.
46. Usuda, J.; Kato, H.; Okunaka, T.; Furukawa, K.; Tsutsui, H.; Yamada, K.; Suga, Y.; Honda, H.; Nagatsuka, Y.; Ohira, T.; et al. Photodynamic therapy (PDT) for lung cancers. J. Thorac. Oncol. 2006, 1, 489-493.
47. Batlle, A.M. Porphyrins, porphyrias, cancer and photodynamic therapy—A model for carcinogenesis. J. Photochem. Photobiol. B Biol. 1993, 20, 5-22.
48. Dougherty, T.J. An update on photodynamic therapy applications. J. Clin. Laser Med. Surg. 2002, 20, 3-7.
49. Morton, C.A.; Brown, S.B.; Collins, S.; Ibbotson, S.; Jenkinson, H.; Kurwa, H.; Langmack, K.; McKenna, K.; Moseley, H.; Pearse, A.D.; et al. Guidelines for topical photodynamic therapy: Report of a workshop of the British Photodermatology Group. Br. J. Dermatol. 2002, 146, 552-567.
50. Peng, Q.; Berg, K.; Moan, J.; Kongshaug, M.; Nesland, J.M. 5-Aminolevulinic acid-based photodynamic therapy: Principles and experimental research. Photochem. Photobiol. 1997, 65, 235-251.
51. Lee, J.W.; Lee, H.I.; Kim, M.N.; Kim, B.J.; Chun, Y.J.; Kim, D. Topical photodynamic therapy with methyl aminolevulinate may be an alternative therapeutic option for the recalcitrant Malassezia folliculitis. Int. J. Dermatol. 2011, 50, 488-490.
52. Morton, C.A. Methyl aminolevulinate: Actinic keratoses and Bowen’s disease. Dermatol. Clin. 2007, 25, 81-87.
53. Dolmans, D.E.; Fukumura, D.; Jain, R.K. Photodynamic therapy for cancer. Nat. Rev. Cancer 2003, 3, 380-387.
54. Senge, M.O.; Brandt, J.C. Temoporfin (Foscan(R), 5,10,15,20-tetra(m-hydroxyphenyl)chlorin)—A second-generation photosensitizer. Photochem. Photobiol. 2011, 87, 1240-1296.
55. Triesscheijn, M.; Ruevekamp, M.; Aalders, M.; Baas, P.; Stewart, F.A. Outcome of mTHPC mediated photodynamic therapy is primarily determined by the vascular response. Photochem. Photobiol. 2005, 81, 1161-1167.
56. Kobayashi, W.; Liu, Q.; Nakagawa, H.; Sakaki, H.; Teh, B.; Matsumiya, T.; Yoshida, H.; Imaizumi, T.; Satoh, K.; Kimura, H. Photodynamic therapy with mono-L-aspartyl chlorin e6 can cause necrosis of squamous cell carcinoma of tongue: Experimental study on an animal model of nude mouse. Oral Oncol. 2006, 42, 46-50.
57. Liang, X.-H.; Cai, Y.-J.; Liao, X.-R.; Wu, K.; Wang, L.; Zhang, D.-B.; Meng, Q. Isolation and identification of a new hypocrellin A-producing strain Shiraia sp. SUPER-H 168. Microbiol. Res. 2009, 164, 9-17.
58. Hudson, J.B.; Zhou, J.; Chen, J.; Harris, L.; Yip, L.; Towers, G.H.N. Hypocrellin, from hypocrella bambuase, is phototoxic to human immunodeficiency virus. Photochem. Photobiol. 1994, 60, 253-255.
59. Tang, P.M.; Liu, X.Z.; Zhang, D.M.; Fong, W.P.; Fung, K.P. Pheophorbide a based photodynamic therapy induces apoptosis via mitochondrial-mediated pathway in human uterine carcinosarcoma. Cancer Biol. Ther. 2009, 8, 533-539.
60. Busch, T.; Cengel, K.A.; Finlay, J. Pheophorbide a as a photosensitizer in photodynamic therapy: In vivo considerations. Cancer Biol. Ther. 2009, 8, 540-542.
61. Kato, H.; Furukawa, K.; Sato, M.; Okunaka, T.; Kusunoki, Y.; Kawahara, M.; Fukuoka, M.; Miyazawa, T.; Yana, T.; Matsui, K.; et al. Phase II clinical study of photodynamic therapy using mono-L-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung. Lung Cancer 2003, 42, 103-111.
62. Lee, L.S.; Thong, P.S.P.; Olivo, M.; Chin, W.W.L.; Ramaswamy, B.; Kho, K.W.; Lim, P.L.; Lau, W.K.O. Chlorin e6-polyvinylpyrrolidone mediated photodynamic therapy—A potential bladder sparing option for high risk non-muscle invasive bladder cancer. Photodiagn. Photodyn. Ther. 2010, 7, 213-220.
63. Chin, W.W.L.; Heng, P.W.S.; Thong, P.S.P.; Bhuvaneswari, R.; Hirt, W.; Kuenzel, S.; Soo, K.C.; Olivo, M. Improved formulation of photosensitizer chlorin e6 polyvinylpyrrolidone for fluorescence diagnostic imaging and photodynamic therapy of human cancer. Eur. J. Pharm. Biopharm. 2008, 69, 1083-1093.
64. Samy, N.A.; Salah, M.M.; Ali, M.F.; Sadek, A.M. Effect of methylene blue-mediated photodynamic therapy for treatment of basal cell carcinoma. LasersMed. Sci. 2015, 30, 109-115.
65. Tardivo, J.P.; del Giglio, A.; de Oliveira, C.S.; Gabrielli, D.S.; Junqueira, H.C.; Tada, D.B.; Severino, D.; de Fátima Turchiello, R.; Baptista, M.S. Methylene blue in photodynamic therapy: From basic mechanisms to clinical applications. Photodiagn. Photodyn. Ther. 2005, 2, 175-191.
66. Saw, C.L.; Heng, P.W.; Olivo, M. Potentiation of the photodynamic action of hypericin. J. Environ. Pathol. Toxicol. Oncol. 2008, 27, 23-33.
67. Wang, X.; Guo, Y.; Yang, S.; Wang, C.; Fu, X.; Wang, J.; Mao, Y.; Zhang, J.; Li, Y. Cellular and molecular mechanisms of photodynamic hypericin therapy for nasopharyngeal carcinoma cells. J. Pharmacol. Exp. Ther. 2010, 334, 847-853.
68. Kinsella, T.J.; Baron, E.D.; Colussi, V.C.; Cooper, K.D.; Hoppel, C.L.; Ingalls, S.T.; Kenney, M.E.; Li, X.; Oleinick, N.L.; Stevens, S.R.; et al. Preliminary Clinical and Pharmacologic Investigation of Photodynamic Therapy with the Silicon Phthalocyanine Photosensitizer Pc 4 for Primary or Metastatic Cutaneous Cancers. Front. Oncol. 2011, 1, 14.
69. Alexander, W. American Society of Clinical Oncology, 2010 Annual Meeting and Rose Bengal: From a Wool Dye to a Cancer Therapy. Pharm. Ther. 2010, 35, 469-478.
70. O’Connor, A.E.; Gallagher, W.M.; Byrne, A.T. Porphyrin and Nonporphyrin Photosensitizers in Oncology: Preclinical and Clinical Advances in Photodynamic Therapy. Photochem. Photobiol. 2009, 85, 1053-1074.
71. Lobel, J.; MacDonald, I.J.; Ciesielski, M.J.; Barone, T.; Potter, W.R.; Pollina, J.; Plunkett, R.J.; Fenstermaker, R.A.; Dougherty, T.J. 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) in a nude rat glioma model: Implications for photodynamic therapy. Lasers Surg. Med. 2001, 29, 397-405.
72. Brancaleon, L.; Moseley, H. Laser and non-laser light sources for photodynamic therapy. Lasers Med. Sci. 2002, 17, 173-186.
73. Peng, F.; Wu, H.; Zheng, Y.; Xu, X.; Yu, J. The effect of noncoherent red light irradiation on proliferation and osteogenic differentiation of bone marrow mesenchymal stem cells. Lasers Med. Sci. 2012, 27, 645-653.
74. Sibata, C.; Colussi, V.; Oleinick, N.; Kinsella, T. Photodynamic therapy: A new concept in medical treatment. Braz. J. Med. Biol. Res. 2000, 33, 869-880.
75. Mang, T.S. Lasers and light sources for PDT: Past, present and future. Photodiagn. Photodyn. Ther. 2004, 1, 43-48.
76. Mizeret, J.C.; van den Bergh, H.E. Cylindrical fiberoptic light diffuser for medical applications. Lasers Surg. Med. 1996, 19, 159-167.
77. Maeda, H. SMANCS and polymer-conjugated macromolecular drugs: Advantages in cancer chemotherapy. Adv. Drug Deliv. Rev. 2001, 46, 169-185.
78. Maeda, H. Tumor-Selective Delivery of Macromolecular Drugs via the EPR Effect: Background and Future Prospects. Bioconjug. Chem. 2010, 21, 797-802.
79. Kobayashi, H.; Watanabe, R.; Choyke, P.L. Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target? Theranostics 2014, 4, 81-89.
80. Felice, B.; Prabhakaran, M.P.; Rodriguez, A.P.; Ramakrishna, S. Drug delivery vehicles on a nano-engineering perspective. Mater. Sci. Eng. C Mater. Biol. Appl. 2014, 41, 178-195.
81. Lassalle, H.P.; Wagner, M.; Bezdetnaya, L.; Guillemin, F.; Schneckenburger, H. Fluorescence imaging of Foscan and Foslip in the plasma membrane and in whole cells. J. Photochem. Photobiol. B Biol. 2008, 92, 47-53.
82. Olivo, M.; Bhuvaneswari, R.; Lucky, S.S.; Dendukuri, N.; Soo-Ping Thong, P. Targeted therapy of cancer using photodynamic therapy in combination with multi-faceted anti-tumor modalities. Pharmaceuticals 2010, 3, 1507-1529.
83. Sharman, W. Targeted photodynamic therapy via receptor mediated delivery systems. Adv. Drug Deliv. Rev. 2004, 56, 53-76.
84. Kozlowska, D.; Foran, P.; MacMahon, P.; Shelly, M.J.; Eustace, S.; O’Kennedy, R. Molecular and magnetic resonance imaging: The value of immunoliposomes. Adv. Drug Deliv. Rev. 2009, 61, 1402-1411.
85. Ormond, A.B.; Freeman, H.S. Dye sensitizers for photodynamic therapy. Materials 2013, 6, 817-840.
86. Luo, C.; Sun, J.; Sun, B.; He, Z. Prodrug-based nanoparticulate drug delivery strategies for cancer therapy. Trends Pharmacol. Sci. 2014, 35, 556-566.
87. Florence, A.T.; Hussain, N. Transcytosis of nanoparticle and dendrimer delivery systems: Evolving vistas. Adv. Drug Deliv. Rev. 2001, 50, 69-89.
88. Konan, Y.N.; Gurny, R.; Allémann, E. State of the art in the delivery of photosensitizers for photodynamic therapy. J. Photochem. Photobiol. B Biol. 2002, 66, 89-106.
89. Mitragotri, S.; Stayton, P. Organic nanoparticles for drug delivery and imaging. MRS Bull. 2014, 39, 219-223.
90. López-Dávila, V.; Seifalian, A.M.; Loizidou, M. Organic nanocarriers for cancer drug delivery. Curr. Opin. Pharmacol. 2012, 12, 414-419.
91. Akbarzadeh, A.; Rezaei-Sadabady, R.; Davaran, S.; Joo, S.W.; Zarghami, N.; Hanifehpour, Y.; Samiei, M.; Kouhi, M.; Nejati-Koshki, K. Liposome: Classification, preparation, and applications. Nanoscale Res. Lett. 2013, 8, 102.
92. Sawant, R.R.; Torchilin, V.P. Liposomes as ‘smart’ pharmaceutical nanocarriers. Soft Matter 2010, 6, 4026-4044.
93. Jiang, F.; Lilge, L.; Grenier, J.; Li, Y.; Wilson, M.D.; Chopp, M. Photodynamic therapy of U87 human glioma in nude rat using liposome-delivered photofrin. Lasers Surg. Med. 1998, 22, 74-80.
94. Jiang, F.; Lilge, L.; Logie, B.; Li, Y.; Chopp, M. Photodynamic therapy of 9L gliosarcoma with liposome-delivered photofrin. Photochem. Photobiol. 1997, 65, 701-706.
95. Lilge, L.; Wilson, B.C. Photodynamic therapy of intracranial tissues: A preclinical comparative study of four different photosensitizers. J. Clin. Laser Med. Surg. 1998, 16, 81-91.
96. Cattel, L.; Ceruti, M.; Dosio, F. From conventional to stealth liposomes: A new frontier in cancer chemotherapy. Tumori 2002, 89, 237-249.
97. Woodle, M.C. Surface-modified liposomes: assessment and characterization for increased stability and prolonged blood circulation. Chem. Phys. Lipids 1993, 64, 249-262.
98. Sadzuka, Y.; Iwasaki, F.; Sugiyama, I.; Horiuchi, K.; Hirano, T.; Ozawa, H.; Kanayama, N.; Oku, N. Phototoxicity of coproporphyrin as a novel photodynamic therapy was enhanced by liposomalization. Toxicol. Lett. 2008, 182, 110-114.
99. Wang, Z.J.; He, Y.Y.; Huang, C.G.; Huang, J.S.; Huang, Y.C.; An, J.Y.; Gu, Y.; Jiang, L.J. Pharmacokinetics, tissue distribution and photodynamic therapy efficacy of liposomal-delivered hypocrellin A, a potential photosensitizer for tumor therapy. Photochem. Photobiol. 1999, 70, 773-780.
100. Derycke, A.S.L.; de Witte, P.A.M. Liposomes for photodynamic therapy. Adv. Drug Deliv. Rev. 2004, 56, 17-30.
101. Namiki, Y.; Namiki, T.; Date, M.; Yanagihara, K.; Yashiro, M.; Takahashi, H. Enhanced photodynamic antitumor effect on gastric cancer by a novel photosensitive stealth liposome. Pharmacol. Res. 2004, 50, 65-76.
102. Kepczynski, M.; Nawalany, K.; Jachimska, B.; Romek, M.; Nowakowska, M. Pegylated tetraarylporphyrin entrapped in liposomal membranes. A possible novel drug-carrier system for photodynamic therapy. Colloids Surf. B Biointerfaces 2006, 49, 22-30.
103. Nawalany, K.; Rusin, A.; Kepczynski, M.; Mikhailov, A.; Kramer-Marek, G.; Snietura, M.; Poltowicz, J.; Krawczyk, Z.; Nowakowska, M. Comparison of photodynamic efficacy of tetraarylporphyrin pegylated or encapsulated in liposomes: In vitro studies. J. Photochem. Photobiol. B Biol. 2009, 97, 8-17.
104. Nawalany, K.; Rusin, A.; Kepczynski, M.; Filipczak, P.; Kumorek, M.; Kozik, B.; Weitman, H.; Ehrenberg, B.; Krawczyk, Z.; Nowakowska, M. Novel nanostructural photosensitizers for photodynamic therapy: In vitro studies. Int. J. Pharm. 2012, 430, 129-140.
105. Muehlmann, L.A.; Joanitti, G.A.; Silva, J.R.; Longo, J.P.F.; Azevedo, R.B. Liposomal photosensitizers: Potential platforms for anticancer photodynamic therapy. Braz. J. Med. Biol. Res. 2011, 44, 729-737.
106. Bressler, N.M.; Bressler, S.B. Photodynamic therapy with verteporfin (Visudyne): Impact on ophthalmology and visual sciences. Investig. Ophthalmol. Vis. Sci. 2000, 41, 624-628.
107. Chakravarthi, S.S.; Robinson, D.H.; De, S. Nanoparticles prepared using natural and synthetic polymers. In Nanoparticulate Drug Delivery Systems; Thassu, D., Deleers, M., Pathak, Y.V., Eds.; CRC Press, Boca Raton, FL, USA, 2007; Volume 3, p. 51.
108. Wang, S.; Fan, W.; Kim, G.; Hah, H.J.; Lee, Y.E.; Kopelman, R.; Ethirajan, M.; Gupta, A.; Goswami, L.N.; Pera, P.; et al. Novel methods to incorporate photosensitizers into nanocarriers for cancer treatment by photodynamic therapy. Lasers Surg. Med. 2011, 43, 686-695.
109. Elzoghby, A.O.; Samy, W.M.; Elgindy, N.A. Albumin-based nanoparticles as potential controlled release drug delivery systems. J. Control. Release 2012, 157, 168-182.
110. Choi, K.Y.; Chung, H.; Min, K.H.; Yoon, H.Y.; Kim, K.; Park, J.H.; Kwon, I.C.; Jeong, S.Y. Self-assembled hyaluronic acid nanoparticles for active tumor targeting. Biomaterials 2010, 31, 106-114.
111. Sailaja, A.; Amareshwar, P.; Chakravarty, P. Different techniques used for the preparation of nanoparticles using natural polymers and their application. Int. J. Pharm. Pharm. Sci. 2011, 3, 45-50.
112. Panyam, J.; Labhasetwar, V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 2003, 55, 329-347.
113. Bugaj, A.M. Targeted photodynamic therapy—A promising strategy of tumor treatment. Photochem. Photobiol. Sci. 2011, 10, 1097-1109.
114. Nair, L.S.; Laurencin, C.T. Biodegradable polymers as biomaterials. Prog. Polym. Sci. 2007, 32, 762-798.
115. Langer, K.; Anhorn, M.G.; Steinhauser, I.; Dreis, S.; Celebi, D.; Schrickel, N.; Faust, S.; Vogel, V. Human serum albumin (HSA) nanoparticles: Reproducibility of preparation process and kinetics of enzymatic degradation. Int. J. Pharm. 2008, 347, 109-117.
116. Fasano, M.; Curry, S.; Terreno, E.; Galliano, M.; Fanali, G.; Narciso, P.; Notari, S.; Ascenzi, P. The extraordinary ligand binding properties of human serum albumin. IUBMB Life 2005, 57, 787-796.
117. Gong, J.; Huo, M.; Zhou, J.; Zhang, Y.; Peng, X.; Yu, D.; Zhang, H.; Li, J. Synthesis, characterization, drug-loading capacity and safety of novel octyl modified serum albumin micelles. Int. J. Pharm. 2009, 376, 161-168.
118. Wacker, M.; Chen, K.; Preuss, A.; Possemeyer, K.; Roeder, B.; Langer, K. Photosensitizer loaded HSA nanoparticles. I: Preparation and photophysical properties. Int. J. Pharm. 2010, 393, 254-263.
119. Chen, K.; Wacker, M.; Hackbarth, S.; Ludwig, C.; Langer, K.; Roder, B. Photophysical evaluation of mTHPC-loaded HSA nanoparticles as novel PDT delivery systems. J. Photochem. Photobiol. B Biol. 2010, 101, 340-347.
120. Chen, K.; Preuss, A.; Hackbarth, S.; Wacker, M.; Langer, K.; Roder, B. Novel photosensitizer-protein nanoparticles for photodynamic therapy: Photophysical characterization and in vitro investigations. J. Photochem. Photobiol. B Biol. 2009, 96, 66-74.
121. Huang, Y.-Y.; Sharma, S.K.; Dai, T.; Chung, H.; Yaroslavsky, A.; Garcia-Diaz, M.; Chang, J.; Chiang, L.Y.; Hamblin, M.R. Can nanotechnology potentiate photodynamic therapy? Nanotechnol. Rev. 2012, 1, 111-146.
122. Nagpal, K.; Singh, S.K.; Mishra, D.N. Chitosan nanoparticles: A promising system in novel drug delivery. Chem. Pharm. Bull. 2010, 58, 1423-1430.
123. Coelho, J.F.; Ferreira, P.C.; Alves, P.; Cordeiro, R.; Fonseca, A.C.; Góis, J.R.; Gil, M.H. Drug delivery systems: Advanced technologies potentially applicable in personalized treatments. EPMA J. 2010, 1, 164-209.
124. Sinha, V.R.; Singla, A.K.; Wadhawan, S.; Kaushik, R.; Kumria, R.; Bansal, K.; Dhawan, S. Chitosan microspheres as a potential carrier for drugs. Int. J. Pharm. 2004, 274, 1-33.
125. Grenha, A. Chitosan nanoparticles: A survey of preparation methods. J. Drug Target. 2012, 20, 291-300.
126. Ghadi, A.; Mahjoub, S.; Tabandeh, F.; Talebnia, F. Synthesis and optimization of chitosan nanoparticles: Potential applications in nanomedicine and biomedical engineering. Casp. J. Int. Med. 2014, 5, 156-161.
127. Zhang, L.; Dou, S.; Li, Y.; Yuan, Y.; Ji, Y.; Wang, Y.; Yang, Y. Degradation and compatibility behaviors of poly(glycolic acid) grafted chitosan. Mater. Sci. Eng. C Mater. Biol. Appl. 2013, 33, 2626-2631.
128. Wang, J.J.; Zeng, Z.W.; Xiao, R.Z.; Xie, T.; Zhou, G.L.; Zhan, X.R.; Wang, S.L. Recent advances of chitosan nanoparticles as drug carriers. Int. J. Nanomed. 2011, 6, 765-774.
129. Nam, H.Y.; Kwon, S.M.; Chung, H.; Lee, S.Y.; Kwon, S.H.; Jeon, H.; Kim, Y.; Park, J.H.; Kim, J.; Her, S.; et al. Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles. J. Control. Release 2009, 135, 259-267.
130. Lee, S.J.; Park, K.; Oh, Y.K.; Kwon, S.H.; Her, S.; Kim, I.S.; Choi, K.; Lee, S.J.; Kim, H.; Lee, S.G.; et al. Tumor specificity and therapeutic efficacy of photosensitizer-encapsulated glycol chitosan-based nanoparticles in tumor-bearing mice. Biomaterials 2009, 30, 2929-2939.
131. Lee, S.J.; Koo, H.; Jeong, H.; Huh, M.S.; Choi, Y.; Jeong, S.Y.; Byun, Y.; Choi, K.; Kim, K.; Kwon, I.C. Comparative study of photosensitizer loaded and conjugated glycol chitosan nanoparticles for cancer therapy. J. Control. Release 2011, 152, 21-29.
132. Bae, B.C.; Na, K. Self-quenching polysaccharide-based nanogels of pullulan/folate-photosensitizer conjugates for photodynamic therapy. Biomaterials 2010, 31, 6325-6335.
133. Oh, I.H.; Min, H.S.; Li, L.; Tran, T.H.; Lee, Y.K.; Kwon, I.C.; Choi, K.; Kim, K.; Huh, K.M. Cancer cell-specific photoactivity of pheophorbide a-glycol chitosan nanoparticles for photodynamic therapy in tumor-bearing mice. Biomaterials 2013, 34, 6454-6463.
134. Mero, A.; Campisi, M. Hyaluronic Acid Bioconjugates for the Delivery of Bioactive Molecules. Polymers 2014, 6, 346-369.
135. Laurent, T.C.; Fraser, J. Hyaluronan. FASEB J. 1992, 6, 2397-2404.
136. Necas, J.; Bartosikova, L.; Brauner, P.; Kolar, J. Hyaluronic acid (hyaluronan): A review. Vet. Med. 2008, 53, 397-411.
137. Burdick, J.A.; Prestwich, G.D. Hyaluronic acid hydrogels for biomedical applications. Adv. Mater. 2011, 23, H41-H56.
138. Galus, R.; Antiszko, M.; Wlodarski, P. Clinical applications of hyaluronic acid. Pol. Merkur. Lekarski 2006, 20, 606-608.
139. Williams, D.L.; Mann, B.K. Efficacy of a crosslinked hyaluronic acid-based hydrogel as a tear film supplement: A masked controlled study. PLoS ONE 2014, 9, e99766.
140. Evanko, S.P.; Parks, W.T.; Wight, T.N. Intracellular hyaluronan in arterial smooth muscle cells: Association with microtubules, RHAMM, and the mitotic spindle. J. Histochem. Cytochem. 2004, 52, 1525-1535.
141. Chen, S.H.; Chen, C.H.; Shalumon, K.; Chen, J.P. Preparation and characterization of antiadhesion barrier film from hyaluronic acid-grafted electrospun poly(caprolactone) nanofibrous membranes for prevention of flexor tendon postoperative peritendinous adhesion. Int. J. Nanomed. 2014, 9, 4079-4092.
142. Moseley, R.; Walker, M.; Waddington, R.; Chen, W. Comparison of the antioxidant properties of wound dressing materials-carboxymethylcellulose, hyaluronan benzyl ester and hyaluronan, towards polymorphonuclear leukocyte-derived reactive oxygen species. Biomaterials 2003, 24, 1549-1557.
143. Evanich, J.D.; Evanich, C.J.; Wright, M.B.; Rydlewicz, J.A. Efficacy of intraarticular hyaluronic acid injections in knee osteoarthritis. Clin. Orthop. Relat. Res. 2001, 390, 173-181.
144. Misra, S.; Heldin, P.; Hascall, V.C.; Karamanos, N.K.; Skandalis, S.S.; Markwald, R.R.; Ghatak, S. Hyaluronan-CD44 interactions as potential targets for cancer therapy. FEBS J. 2011, 278, 1429-1443.
145. Yoon, H.Y.; Koo, H.; Choi, K.Y.; Lee, S.J.; Kim, K.; Kwon, I.C.; Leary, J.F.; Park, K.; Yuk, S.H.; Park, J.H.; et al. Tumor-targeting hyaluronic acid nanoparticles for photodynamic imaging and therapy. Biomaterials 2012, 33, 3980-3989.
146. Luo, Y.; Prestwich, G.D. Synthesis and Selective Cytotoxicity of a Hyaluronic Acid−Antitumor Bioconjugate. Bioconjug. Chem. 1999, 10, 755-763.
147. Li, F.; Bae, B.-C.; Na, K. Acetylated Hyaluronic Acid/Photosensitizer Conjugate for the Preparation of Nanogels with Controllable Phototoxicity: Synthesis, Characterization, Autophotoquenching Properties, and in vitro Phototoxicity against HeLa Cells. Bioconjug. Chem. 2010, 21, 1312-1320.
148. Neuse, E.W. Synthetic polymers as drug-delivery vehicles in medicine. Metal-Based Drugs 2008, 2008, 469531.
149. Liechty, W.B.; Kryscio, D.R.; Slaughter, B.V.; Peppas, N.A. Polymers for Drug Delivery Systems. Annu. Rev. Chem. Biomol. 2010, 1, 149-173.
150. Kim, S.; Shi, Y.; Kim, J.Y.; Park, K.; Cheng, J.X. Overcoming the barriers in micellar drug delivery: Loading efficiency, in vivo stability, and micelle-cell interaction. Expert Opin. Drug Del. 2010, 7, 49-62.
151. Sant, V.P.; Smith, D.; Leroux, J.-C. Enhancement of oral bioavailability of poorly water-soluble drugs by poly(ethylene glycol)-block-poly(alkyl acrylate-co-methacrylic acid) self-assemblies. J. Control. Release 2005, 104, 289-300.
152. Avgoustakis, K.; Beletsi, A.; Panagi, Z.; Klepetsanis, P.; Karydas, A.G.; Ithakissios, D.S. PLGA-mPEG nanoparticles of cisplatin: In vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. J. Control. Release 2002, 79, 123-135.
153. Meng, F.T.; Ma, G.H.; Qiu, W.; Su, Z.G. W/O/W double emulsion technique using ethyl acetate as organic solvent: Effects of its diffusion rate on the characteristics of microparticles. J. Control. Release 2003, 91, 407-416.
154. Song, C.X.; Labhasetwar, V.; Murphy, H.; Qu, X.; Humphrey, W.R.; Shebuski, R.J.; Levy, R.J. Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery. J. Control. Release 1997, 43, 197-212.
155. Xie, J.; Wang, C.H. Self-assembled biodegradable nanoparticles developed by direct dialysis for the delivery of paclitaxel. Pharm. Res. 2005, 22, 2079-2090.
156. Jette, K.; Law, D.; Schmitt, E.; Kwon, G. Preparation and drug loading of poly(ethylene glycol)-block-poly(ε-caprolactone) micelles through the evaporation of a cosolvent azeotrope. Pharm. Res. 2004, 21, 1184-1191.
157. Pinon-Segundo, E.; Nava-Arzaluz, M.G.; Lechuga-Ballesteros, D. Pharmaceutical polymeric nanoparticles prepared by the double emulsion-solvent evaporation technique. Recent Pat. Drug Deliv. Formul. 2012, 6, 224-235.
158. Fournier, E.; Dufresne, M.H.; Smith, D.C.; Ranger, M.; Leroux, J.C. A novel one-step drug-loading procedure for water-soluble amphiphilic nanocarriers. Pharm. Res. 2004, 21, 962-968.
159. Miller, T.; van Colen, G.; Sander, B.; Golas, M.; Uezguen, S.; Weigandt, M.; Goepferich, A. Drug Loading of Polymeric Micelles. Pharm. Res. 2013, 30, 584-595.
160. Schmaljohann, D. Thermo-and pH-responsive polymers in drug delivery. Adv. Drug Deliver. Rev. 2006, 58, 1655-1670.
161. Meng, F.; Zhong, Z.; Feijen, J. Stimuli-responsive polymersomes for programmed drug delivery. Biomacromolecules 2009, 10, 197-209.
162. Angammana, C.J.; Jayaram, S.H. Effects of ionic carriers on the morphological properties of electrospun nanofibres. In Electrical Insulation and Dielectric Phenomena (CEIDP). Proceedings of the 2010 Annual Report Conference, West Lafayette, IN, USA, 17-20 October 2010; IEEE: West Lafayette, IN, USA, 2010; pp. 1-4.
163. Asare-Addo, K.; Conway, B.R.; Larhrib, H.; Levina, M.; Rajabi-Siahboomi, A.R.; Tetteh, J.; Boateng, J.; Nokhodchi, A. The effect of pH and ionic strength of dissolution media on in vitro release of two model drugs of different solubilities from HPMC matrices. Colloids Surf. B Biointerfaces 2013, 111, 384-391.
164. Emileh, A.; Vasheghani-Farahani, E.; Imani, M. Swelling behavior, mechanical properties and network parameters of pH-and temperature-sensitive hydrogels of poly((2-dimethyl amino) ethyl methacrylate-co-butyl methacrylate). Eur. Polym. J. 2007, 43, 1986-1995.
165. Wu, W.; Liu, J.; Cao, S.; Tan, H.; Li, J.; Xu, F.; Zhang, X. Drug release behaviors of a pH sensitive semi-interpenetrating polymer network hydrogel composed of poly(vinyl alcohol) and star poly [2-(dimethylamino)ethyl methacrylate]. Int. J. Pharm. 2011, 416, 104-109.
166. Huh, K.; Kang, H.; Lee, Y.; Bae, Y. pH-sensitive polymers for drug delivery. Macromol. Res. 2012, 20, 224-233.
167. Gil, E.S.; Hudson, S.M. Stimuli-reponsive polymers and their bioconjugates. Prog. Polym. Sci. 2004, 29, 1173-1222.
168. Aguilar, M.; Elvira, C.; Gallardo, A.; Vázquez, B.; Román, J. Smart Polymers and Their Applications as Biomaterials. Top. Tissue Eng. 2007, 3, 6.
169. Kim, S.Y.; Cho, S.M.; Lee, Y.M.; Kim, S.J. Thermo-and pH-responsive behaviors of graft copolymer and blend based on chitosan and N-isopropylacrylamide. J. Appl. Polym. Sci. 2000, 78, 1381-1391.
170. Mitragotri, S.; Lahann, J. Physical approaches to biomaterial design. Nat. Mater. 2009, 8, 15-23.
171. Kyriakides, T.R.; Cheung, C.Y.; Murthy, N.; Bornstein, P.; Stayton, P.S.; Hoffman, A.S. pH-Sensitive polymers that enhance intracellular drug delivery in vivo. J. Control. Release 2002, 78, 295-303.
172. Park, S.Y.; Bae, Y.H. Novel pH-sensitive polymers containing sulfonamide groups. Macromol. Rapid Commun. 1999, 20, 269-273.
173. Ghosh, P. Hydrophilic polymeric nanoparticles as drug carriers. Indian J. Biochem. Biophys. 2000, 37, 273-282.
174. Nagavarma, B.; Ayaz, A.; Vasudha, L.; Shivakumar, H. Different Techniques for Preparation of Polymeric Nanoparticles—A Review. Asian J. Pharm. Clin. Res. 2012, 5, 16-23.
175. Tang, W.; Xu, H.; Park, E.J.; Philbert, M.A.; Kopelman, R. Encapsulation of methylene blue in polyacrylamide nanoparticle platforms protects its photodynamic effectiveness. Biochem. Biophys. Res. Commun. 2008, 369, 579-583.
176. Brigger, I.; Dubernet, C.; Couvreur, P. Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliv. Rev. 2002, 54, 631-651.
177. Soppimath, K.S.; Aminabhavi, T.M.; Kulkarni, A.R.; Rudzinski, W.E. Biodegradable polymeric nanoparticles as drug delivery devices. J. Control. Release 2001, 70, 1-20.
178. Gao, D.; Agayan, R.R.; Xu, H.; Philbert, M.A.; Kopelman, R. Nanoparticles for Two-Photon Photodynamic Therapy in Living Cells. Nano Lett. 2006, 6, 2383-2386.
179. Park, S.; Bearinger, J.; Lautenschlager, E.; Castner, D.; Healy, K. Surface modification of poly (ethylene terephthalate) angioplasty balloons with a hydrophilic poly (acrylamide-co-ethylene glycol) interpenetrating polymer network coating. J. Biomed. Mater. Res. 2000, 53, 568-576.
180. Moreno, M.J.; Monson, E.; Reddy, R.G.; Rehemtulla, A.; Ross, B.D.; Philbert, M.; Schneider, R.J.; Kopelman, R. Production of singlet oxygen by Ru(dpp(SO3)2)3 incorporated in polyacrylamide PEBBLES. Sens. Actuators B Chem. 2003, 90, 82-89.
181. Anderson, J.M.; Shive, M.S. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Deliv. Rev. 1997, 28, 5-24.
182. Bertin, A. Emergence of Polymer Stereocomplexes for Biomedical Applications. Macromol. Chem. Phys. 2012, 213, 2329-2352.
183. Middleton, J.C.; Tipton, A.J. Synthetic biodegradable polymers as orthopedic devices. Biomaterials 2000, 21, 2335-2346.
184. Bergsma, J.E.; Rozema, F.R.; Bos, R.R.M.; Boering, G.; de Bruijn, W.C.; Pennings, A.J. In vivo degradation and biocompatibility study of in vitro pre-degraded as-polymerized polylactide particles. Biomaterials 1995, 16, 267-274.
185. Rancan, F.; Papakostas, D.; Hadam, S.; Hackbarth, S.; Delair, T.; Primard, C.; Verrier, B.; Sterry, W.; Blume-Peytavi, U.; Vogt, A. Investigation of polylactic acid (PLA) nanoparticles as drug delivery systems for local dermatotherapy. Pharm. Res. 2009, 26, 2027-2036.
186. Lavie, G.; Mazur, Y.; Lavie, D.; Meruelo, D. The chemical and biological properties of hypericin—A compound with a broad spectrum of biological activities. Med. Res. Rev. 1995, 15, 111-119.
187. Zeisser-Labouebe, M.; Lange, N.; Gurny, R.; Delie, F. Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancer. Int. J. Pharm. 2006, 326, 174-181.
188. Karavelidis, V.; Karavas, E.; Giliopoulos, D.; Papadimitriou, S.; Bikiaris, D. Evaluating the effects of crystallinity in new biocompatible polyester nanocarriers on drug release behavior. Int. J. Nanomed. 2011, 6, 3021-3032.
189. Kumari, A.; Yadav, S.K.; Yadav, S.C. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf. B Biointerfaces 2010, 75, 1-18.
190. Gaucher, G.; Dufresne, M.H.; Sant, V.P.; Kang, N.; Maysinger, D.; Leroux, J.C. Block copolymer micelles: Preparation, characterization and application in drug delivery. J. Control. Release 2005, 109, 169-188.
191. Liu, T.; Tian, W.; Zhu, Y.; Bai, Y.; Yan, H.; Du, J. How does a tiny terminal alkynyl end group drive fully hydrophilic homopolymers to self-assemble into multicompartment vesicles and flower-like complex particles? Poly. Chem. 2014, 5, 5077-5088.
192. Rösler, A.; Vandermeulen, G.W.M.; Klok, H.-A. Advanced drug delivery devices via self-assembly of amphiphilic block copolymers. Adv. Drug Deliver. Rev. 2001, 53, 95-108.
193. Kadajji, V.G.; Betageri, G.V. Water soluble polymers for pharmaceutical applications. Polymers 2011, 3, 1972-2009.
194. Makadia, H.K.; Siegel, S.J. Poly lactic-co-glycolic acid (plga) as biodegradable controlled drug delivery carrier. Polymers 2011, 3, 1377-1397.
195. Miller, R.A.; Brady, J.M.; Cutright, D.E. Degradation rates of oral resorbable implants (polylactates and polyglycolates): Rate modification with changes in PLA/PGA copolymer ratios. J. Biomed. Mater. Res. 1977, 11, 711-719.
196. Champion, J.A.; Katare, Y.K.; Mitragotri, S. Particle shape: A new design parameter for micro-and nanoscale drug delivery carriers. J. Control. Release 2007, 121, 3-9.
197. Rejman, J.; Oberle, V.; Zuhorn, I.; Hoekstra, D. Size-dependent internalization of particles via the pathways of clathrin-and caveolae-mediated endocytosis. Biochem. J. 2004, 377, 159-169.
198. Caldorera-Moore, M.; Guimard, N.; Shi, L.; Roy, K. Designer nanoparticles: Incorporating size, shape, and triggered release into nanoscale drug carriers. Expert Opin. Drug Deliv. 2010, 7, 479-495.
199. Vargas, A.; Pegaz, B.; Debefve, E.; Konan-Kouakou, Y.; Lange, N.; Ballini, J.-P.; van den Bergh, H.; Gurny, R.; Delie, F. Improved photodynamic activity of porphyrin loaded into nanoparticles: An in vivo evaluation using chick embryos. Int. J. Pharm. 2004, 286, 131-145.
200. Vargas, A.; Eid, M.; Fanchaouy, M.; Gurny, R.; Delie, F. In vivo photodynamic activity of photosensitizer-loaded nanoparticles: Formulation properties, administration parameters and biological issues involved in PDT outcome. Eur. J. Pharm. Biopharm. 2008, 69, 43-53.
201. Ricci-Junior, E.; Marchetti, J.M. Zinc(II) phthalocyanine loaded PLGA nanoparticles for photodynamic therapy use. Int. J. Pharm. 2006, 310, 187-195.
202. Xiao, R.Z.; Zeng, Z.W.; Zhou, G.L.; Wang, J.J.; Li, F.Z.; Wang, A.M. Recent advances in PEG-PLA block copolymer nanoparticles. Int. J. Nanomed. 2010, 5, 1057-1065.
203. Kolate, A.; Baradia, D.; Patil, S.; Vhora, I.; Kore, G.; Misra, A. PEG—A versatile conjugating ligand for drugs and drug delivery systems. J. Control. Release 2014, 192, 67-81.
204. Matsumoto, J.; Nakada, Y.; Sakurai, K.; Nakamura, T.; Takahashi, Y. Preparation of nanoparticles consisted of poly(l-lactide)-poly(ethylene glycol)-poly(l-lactide) and their evaluation in vitro. Int. J. Pharm. 1999, 185, 93-101.
205. Yang, Z.L.; Li, X.R.; Yang, K.W.; Liu, Y. Amphotericin B-loaded poly(ethylene glycol)-poly(lactide) micelles: Preparation, freeze-drying, and in vitro release. J. Biomed. Mater. Res. Part A 2008, 85, 539-546.
206. Cohen, E.M.; Ding, H.; Kessinger, C.W.; Khemtong, C.; Gao, J.; Sumer, B.D. Polymeric micelle nanoparticles for photodynamic treatment of head and neck cancer cells. Otolaryngol. Head Neck Surg. 2010, 143, 109-115.
207. Bourdon, O.; Mosqueira, V.; Legrand, P.; Blais, J. A comparative study of the cellular uptake, localization and phototoxicity of meta-tetra (hydroxyphenyl) chlorin encapsulated in surface-modified submicronic oil/water carriers in HT29 tumor cells. J. Photochem. Photobiol. B Biol. 2000, 55, 164-171.
208. Labet, M.; Thielemans, W. Synthesis of polycaprolactone: A review. Chem. Soc. Rev. 2009, 38, 3484-3504.
209. Lokhande, A.; Mishra, S.; Kulkarni, R. Formulation and Evaluation of Glipizide loaded nanoparticles. J. Pharm. Pharm. Sci. 2013, 5, 147-151.
210. Ahmed, F.; Discher, D.E. Self-porating polymersomes of PEG-PLA and PEG-PCL: Hydrolysis-triggered controlled release vesicles. J. Control. Release 2004, 96, 37-53.
211. Zhou, S.; Deng, X.; Yang, H. Biodegradable poly (ε-caprolactone)-poly (ethylene glycol) block copolymers: Characterization and their use as drug carriers for a controlled delivery system. Biomaterials 2003, 24, 3563-3570.
212. Master, A.M.; Rodriguez, M.E.; Kenney, M.E.; Oleinick, N.L.; Gupta, A.S. Delivery of the photosensitizer Pc 4 in PEG-PCL micelles for in vitro PDT studies. J. Pharm. Sci. 2010, 99, 2386-2398.
213. Peng, C.L.; Shieh, M.J.; Tsai, M.H.; Chang, C.C.; Lai, P.S. Self-assembled star-shaped chlorin-core poly(epsilon-caprolactone)-poly(ethylene glycol) diblock copolymer micelles for dual chemo-photodynamic therapies. Biomaterials 2008, 29, 3599-3608.
214. Quynh, T.M.; Yoneyamab, M.; Maki, Y.; Dobashi, T. Poly(N-isopropylacrylamide-cohydroxyethyl methacrylate) graft copolymers and their application as carriers for drug delivery system. J. Appl. Polym. Sci. 2012, 123, 2368-2376.
215. Shinoda, H.; Miller, P.J.; Matyjaszewski, K. Improving the Structural Control of Graft Copolymers by Combining ATRP with the Macromonomer Method. Macromolecules 2001, 34, 3186-3194.
216. Xun, W.; Wang, H.-Y.; Li, Z.-Y.; Cheng, S.-X.; Zhang, X.-Z.; Zhuo, R.-X. Self-assembled micelles of novel graft amphiphilic copolymers for drug controlled release. Colloids Surf. B Biointerfaces 2011, 85, 86-91.
217. Bourdon, O.; Laville, I.; Carrez, D.; Croisy, A.; Fedel, P.; Kasselouri, A.; Prognon, P.; Legrand, P.; Blais, J. Biodistribution of meta-tetra(hydroxyphenyl)chlorin incorporated into surface-modified nanocapsules in tumor-bearing mice. Photochem. Photobiol. Sci. 2002, 1, 709-714.
218. Tsai, H.C.; Tsai, C.H.; Lin, S.Y.; Jhang, C.R.; Chiang, Y.S.; Hsiue, G.H. Stimulated release of photosensitizers from graft and diblock micelles for photodynamic therapy. Biomaterials 2012, 33, 1827-1837.
219. Kesharwani, P.; Jain, K.; Jain, N.K. Dendrimer as nanocarrier for drug delivery. Prog. Polym. Sci. 2014, 39, 268-307.
220. Boas, U.; Heegaard, P.M. Dendrimers in drug research. Chem. Soc. Rev. 2004, 33, 43-63.
221. Madaan, K.; Kumar, S.; Poonia, N.; Lather, V.; Pandita, D. Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues. J. Pharm. Bioallied Sci. 2014, 6, 139-150.
222. Tomalia, D.A. Birth of a new macromolecular architecture: Dendrimers as quantized building blocks for nanoscale synthetic polymer chemistry. Prog. Polym. Sci. 2005, 30, 294-324.
223. Jain, A.; Dubey, S.; Kaushik, A.; Tyagi, A. Dendrimer: A complete drug carrier. Int. J. Pharm. Sci. Drug Res. 2010, 1, 38-52.
224. Pan, G.; Lemmouchi, Y.; Akala, E.O.; Bakare, O. Studies on PEGylated and drug-loaded PAMAM dendrimers. J. Bioact. Compat. Polym. 2005, 20, 113-128.
225. Caminade, A.-M.; Turrin, C.-O. Dendrimers for drug delivery. J. Mater. Chem. B 2014, 2, 4055-4066.
226. Battah, S.H.; Chee, C.-E.; Nakanishi, H.; Gerscher, S.; MacRobert, A.J.; Edwards, C. Synthesis and Biological Studies of 5-Aminolevulinic Acid-Containing Dendrimers for Photodynamic Therapy. Bioconjug. Chem. 2001, 12, 980-988.
227. Kojima, C.; Toi, Y.; Harada, A.; Kono, K. Preparation of Poly(ethylene glycol)-Attached Dendrimers Encapsulating Photosensitizers for Application to Photodynamic Therapy. Bioconjug. Chem. 2007, 18, 663-670.
228. Komber, H.; Stumpe, K.; Voit, B. NMR Study of Hyperbranched Polyphenylenes from the AB2, (AB2 + AB) and (A2 + B3) Methods. Macromol. Chem. Phys. 2006, 207, 1814-1824.
229. Gao, C.; Yan, D. Hyperbranched polymers: From synthesis to applications. Prog. Polym. Sci. 2004, 29, 183-275.
230. Shi, Y.; Nabae, Y.; Hayakawa, T.; Kobayashi, H.; Yabushita, M.; Fukuoka, A.; Kakimoto, M.-A. Synthesis and characterization of hyperbranched aromatic poly(ether ketone)s functionalized with carboxylic acid terminal groups. Polym. J. 2014, 46, 722-727.
231. Li, P.; Zhou, G.; Zhu, X.; Li, G.; Yan, P.; Shen, L.; Xu, Q.; Hamblin, M.R. Photodynamic therapy with hyperbranched poly(ether-ester) chlorin(e6) nanoparticles on human tongue carcinoma CAL-27 cells. Photodiagn. Photodyn. Ther. 2012, 9, 76-82.
232. Hamidi, M.; Azadi, A.; Rafiei, P. Hydrogel nanoparticles in drug delivery. Adv. Drug Deliv. Rev. 2008, 60, 1638-1649.
233. Hoare, T.R.; Kohane, D.S. Hydrogels in drug delivery: Progress and challenges. Polymer 2008, 49, 1993-2007.
234. Gupta, A.; Wang, S.; Pera, P.; Rao, K.V.R.; Patel, N.; Ohulchanskyy, T.Y.; Missert, J.; Morgan, J.; Koo-Lee, Y.-E.; Kopelman, R.; et al. Multifunctional Nanoplatforms for Fluorescence Imaging and Photodynamic Therapy Developed by Post-loading Photosensitizer and Fluorophore to Polyacrylamide Nanoparticles. Nanomed. Nanotechnol. Biol. Med. 2012, 8, 941-950.
235. Gao, D.; Xu, H.; Philbert, M.A.; Kopelman, R. Ultrafine hydrogel nanoparticles: Synthetic approach and therapeutic application in living cells. Angew. Chem. 2007, 46, 2224-2227.
236. He, H.; Cattran, A.W.; Nguyen, T.; Nieminen, A.-L.; Xu, P. Triple-responsive expansile nanogel for tumor and mitochondria targeted photosensitizer delivery. Biomaterials 2014, 35, 9546-9553.
237. Safari, J.; Zarnegar, Z. Advanced drug delivery systems: Nanotechnology of health design: A review. J. Saudi Chem. Soc. 2014, 18, 85-99.
238. Zhang, L.; Li, Y.; Yu, J.C. Chemical modification of inorganic nanostructures for targeted and controlled drug delivery in cancer treatment. J. Mater. Chem. B 2014, 2, 452-470.
239. Ojea-Jimenez, I.; Comenge, J.; Garcia-Fernandez, L.; Megson, Z.A.; Casals, E.; Puntes, V.F. Engineered inorganic nanoparticles for drug delivery applications. Curr. Drug Metab. 2013, 14, 518-530.
240. Xu, Z.P.; Zeng, Q.H.; Lu, G.Q.; Yu, A.B. Inorganic nanoparticles as carriers for efficient cellular delivery. Chem. Eng. Sci. 2006, 61, 1027-1040.
241. Dey, N.S.; Rao, M. Quantum dot: Novel carrier for drug delivery. Int. J. Res. Pharm. Biomed. Sci. 2011, 2, 448-458.
242. Ahmad, M.Z.; Akhter, S.; Jain, G.K.; Rahman, M.; Pathan, S.A.; Ahmad, F.J.; Khar, R.K. Metallic nanoparticles: Technology overview & drug delivery applications in oncology. Expert Opin. Drug Deliv. 2010, 7, 927-942.
243. Ladj, R.; Bitar, A.; Eissa, M.; Mugnier, Y.; Le Dantec, R.; Fessi, H.; Elaissari, A. Individual inorganic nanoparticles: Preparation, functionalization and in vitro biomedical diagnostic applications. J. Mater. Chem. B 2013, 1, 1381-1396.
244. Thienot, E.; Germain, M.; Piejos, K.; Simon, V.; Darmon, A.; Marill, J.; Borghi, E.; Levy, L.; Hochepied, J.F.; Pottier, A. One pot synthesis of new hybrid versatile nanocarrier exhibiting efficient stability in biological environment for use in photodynamic therapy. J. Photochem. Photobiol. B Biol. 2010, 100, 1-9.
245. Conde, J.; Dias, J.T.; Grazú, V.; Moros, M.; Baptista, P.V.; de la Fuente, J.M. Revisiting 30 years of biofunctionalization and surface chemistry of inorganic nanoparticles for nanomedicine. Front. Chem. 2014, 2, 48.
246. Faraji, A.H.; Wipf, P. Nanoparticles in cellular drug delivery. Bioorg. Med. Chem. 2009, 17, 2950-2962.
247. Grazu, V.; Moros, M. Nanocarriers as nanomedicines: design concepts and recent advances. In Nanobiotechnology: Inorganic Nanoparticles vs Organic Nanoparticles; de la Fuente, J.M., Grazu, V., Eds.; Elsivier: New York, NY, USA, 2012; Volume 4, pp. 337-385.
248. Kim, B.-S.; Park, S.W.; Hammond, P.T. Hydrogen-Bonding Layer-by-Layer-Assembled Biodegradable Polymeric Micelles as Drug Delivery Vehicles from Surfaces. ACS Nano 2008, 2, 386-392.
249. Kumari, A.; Singla, R.; Guliani, A.; Yadav, S.K. Nanoencapsulation for drug delivery. Available online: http://hdl.handle.net/2003/33542 (accessed on 31 August 2015).
250. Lu, J.; Liong, M.; Zink, J.I.; Tamanoi, F. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. Small 2007, 3, 1341-1346.
251. Manju, S.; Sreenivasan, K. Enhanced Drug Loading on Magnetic Nanoparticles by Layer-by-Layer Assembly Using Drug Conjugates: Blood Compatibility Evaluation and Targeted Drug Delivery in Cancer Cells. Langmuir 2011, 27, 14489-14496.
252. Rosenholm, J.M.; Peuhu, E.; Eriksson, J.E.; Sahlgren, C.; Lindén, M. Targeted Intracellular Delivery of Hydrophobic Agents using Mesoporous Hybrid Silica Nanoparticles as Carrier Systems. Nano Lett. 2009, 9, 3308-3311.
253. Su, Y.; Xie, Z.; Kim, G.B.; Dong, C.; Yang, J. Design strategies and applications of circulating cell mediated drug delivery systems. ACS Biomater. Sci. Eng. 2015, 1, 201-217.
254. Doane, T.; Burda, C. Nanoparticle mediated non-covalent drug delivery(). Adv. Drug Deliv. Rev. 2013, 65, 607-621.
255. Smith, A.M.; Duan, H.; Mohs, A.M.; Nie, S. Bioconjugated quantum dots for in vivo molecular and cellular imaging. Adv. Drug Deliv. Rev. 2008, 60, 1226-1240.
256. Neeleshwar, S.; Chen, C.; Tsai, C.; Chen, Y.; Chen, C.-C.; Shyu, S.; Seehra, M. Size-dependent properties of CdSe quantum dots. Phys. Rev. B 2005, 71, 201307.
257. Probst, C.E.; Zrazhevskiy, P.; Bagalkot, V.; Gao, X. Quantum dots as a platform for nanoparticle drug delivery vehicle design. Adv. Drug Deliv. Rev. 2013, 65, 703-718.
258. Zrazhevskiy, P.; Sena, M.; Gao, X. Designing multifunctional quantum dots for bioimaging, detection, and drug delivery. Chem. Soc. Rev. 2010, 39, 4326-4354.
259. Clift, M.J.D.; Stone, V. Quantum Dots: An Insight and Perspective of Their Biological Interaction and How This Relates to Their Relevance for Clinical Use. Theranostics 2012, 2, 668-680.
260. Jamieson, T.; Bakhshi, R.; Petrova, D.; Pocock, R.; Imani, M.; Seifalian, A.M. Biological applications of quantum dots. Biomaterials 2007, 28, 4717-4732.
261. Poderys, V.; Matulionyte, M.; Selskis, A.; Rotomskis, R. Interaction of water-soluble CdTe quantum dots with bovine serum albumin. Nanoscale Res. Lett. 2011, 6, 9-14.
262. Juzenas, P.; Chen, W.; Sun, Y.P.; Coelho, M.A.; Generalov, R.; Generalova, N.; Christensen, I.L. Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer. Adv. Drug Deliv. Rev. 2008, 60, 1600-1614.
263. Chatterjee, D.K.; Fong, L.S.; Zhang, Y. Nanoparticles in photodynamic therapy: An emerging paradigm. Adv. Drug Deliv. Rev. 2008, 60, 1627-1637.
264. Paszko, E.; Ehrhardt, C.; Senge, M.O.; Kelleher, D.P.; Reynolds, J.V. Nanodrug applications in photodynamic therapy. Photodiagn. Photodyn. Ther. 2011, 8, 14-29.
265. Shao, L.; Gao, Y.; Yan, F. Semiconductor Quantum Dots for Biomedicial Applications. Sensors 2011, 11, 11736-11751.
266. Talapin, D.; Poznyak, S.; Gaponik, N.; Rogach, A.; Eychmüller, A. Synthesis of surface-modified colloidal semiconductor nanocrystals and study of photoinduced charge separation and transport in nanocrystal-polymer composites. Phys. E: Low-Dimens. Syst. Nanostruct. 2002, 14, 237-241.
267. Samia, A.C.S.; Chen, X.; Burda, C. Semiconductor Quantum Dots for Photodynamic Therapy. J. Am. Chem. Soc. 2003, 125, 15736-15737.
268. Rizvi, S.B.; Ghaderi, S.; Keshtgar, M.; Seifalian, A.M. Semiconductor quantum dots as fluorescent probes for in vitro and in vivo bio-molecular and cellular imaging. Nano Rev. 2010, 1, 10.3402.
269. Tsay, J.M.; Trzoss, M.; Shi, L.; Kong, X.; Selke, M.; Jung, M.E.; Weiss, S. Singlet Oxygen Production by Peptide-Coated Quantum Dot−Photosensitizer Conjugates. J. Am. Chem. Soc. 2007, 129, 6865-6871.
270. Cheng, S.-H.; Lee, C.-H.; Chen, M.-C.; Souris, J.S.; Tseng, F.-G.; Yang, C.-S.; Mou, C.-Y.; Chen, C.-T.; Lo, L.-W. Tri-functionalization of mesoporous silica nanoparticles for comprehensive cancer theranostics—The trio of imaging, targeting and therapy. J. Mater. Chem. 2010, 20, 6149.
271. Moreno-Vega, A.-I.; Gómez-Quintero, T.; Nuñez-Anita, R.-E.; Acosta-Torres, L.-S.; Castaño, V.; Polymeric and Ceramic Nanoparticles in Biomedical Applications. J. Nanotechnol. 2012, 2012, 936041.
272. Liong, M.; Lu, J.; Kovochich, M.; Xia, T.; Ruehm, S.G.; Nel, A.E.; Tamanoi, F.; Zink, J.I. Multifunctional Inorganic Nanoparticles for Imaging, Targeting, and Drug Delivery. ACS Nano 2008, 2, 889-896.
273. Brinker, C.; Sehgal, R.; Hietala, S.; Deshpande, R.; Smith, D.; Loy, D.; Ashley, C. Sol-gel strategies for controlled porosity inorganic materials. J. Membr. Sci. 1994, 94, 85-102.
274. Corriu, R.J. Ceramics and nanostructures from molecular precursors. Angew. Chem. Int. Ed. 2000, 39, 1376-1398.
275. Lin, Y.; Kumakiri, I.; Nair, B.; Alsyouri, H. Microporous inorganic membranes. Sep. Purif. Rev. 2002, 31, 229-379.
276. Yang, L.; Sheldon, B.W.; Webster, T.J. Nanophase ceramics for improved drug delivery. Am. Ceram. Soc. Bull. 2010, 89, 24-32.
277. Yang, G.; Gong, H.; Qian, X.; Tan, P.; Li, Z.; Liu, T.; Liu, J.; Li, Y.; Liu, Z. Mesoporous silica nanorods intrinsically doped with photosensitizers as a multifunctional drug carrier for combination therapy of cancer. Nano Res. 2014, 3, 751-764.
278. Kossovsky, N.; Gelman, A.; Sponsler, E.E.; Hnatyszyn, H.J.; Rajguru, S.; Torres, M.; Pham, M.; Crowder, J.; Zemanovich, J.; Chung, A. Surface-modified nanocrystalline ceramics for drug delivery applications. Biomaterials 1994, 15, 1201-1207.
279. Pandey, R.S.; Sahu, S.; Sudheesh, M.; Madan, J.; Kumar, M.; Dixit, V.K. Carbohydrate modified ultrafine ceramic nanoparticles for allergen immunotherapy. Int. Immunopharmacol. 2011, 11, 925-931.
280. Roy, I.; Ohulchanskyy, T.Y.; Pudavar, H.E.; Bergey, E.J.; Oseroff, A.R.; Morgan, J.; Dougherty, T.J.; Prasad, P.N. Ceramic-Based Nanoparticles Entrapping Water-Insoluble Photosensitizing Anticancer Drugs: A Novel Drug−Carrier System for Photodynamic Therapy. J. Am. Chem. Soc. 2003, 125, 7860-7865.
281. Teng, I.T.; Chang, Y.J.; Wang, L.S.; Lu, H.Y.; Wu, L.C.; Yang, C.M.; Chiu, C.C.; Yang, C.H.; Hsu, S.L.; Ho, J.A. Phospholipid-functionalized mesoporous silica nanocarriers for selective photodynamic therapy of cancer. Biomaterials 2013, 34, 7462-7470.
282. Lin, R.; Zhou, L.; Lin, Y.; Wang, A.; Zhou, J.H.; Wei, S.H. Property study of a new silica nanoparticle delivery system of hydrophobic phthalocyanine using spectroscopic method. Spectroscopy 2011, 26, 179-185.
283. Brevet, D.; Gary-Bobo, M.; Raehm, L.; Richeter, S.; Hocine, O.; Amro, K.; Loock, B.; Couleaud, P.; Frochot, C.; Morere, A.; et al. Mannose-targeted mesoporous silica nanoparticles for photodynamic therapy. Chem. Commun. 2009, 12, 1475-1477.
284. Gary-Bobo, M.; Brevet, D.; Benkirane-Jessel, N.; Raehm, L.; Maillard, P.; Garcia, M.; Durand, J.O. Hyaluronic acid-functionalized mesoporous silica nanoparticles for efficient photodynamic therapy of cancer cells. Photodiagn. Photodyn. Ther. 2012, 9, 256-260.
285. Gary-Bobo, M.; Mir, Y.; Rouxel, C.; Brevet, D.; Basile, I.; Maynadier, M.; Vaillant, O.; Mongin, O.; Blanchard-Desce, M.; Morère, A.; et al. Mannose-Functionalized Mesoporous Silica Nanoparticles for Efficient Two-Photon Photodynamic Therapy of Solid Tumors. Angew. Chem. Int. Ed. 2011, 50, 11425-11429.
286. Conde, J.; Doria, G.; Baptista, P. Noble metal nanoparticles applications in cancer. J. Drug Deliv. 2012, 2012, 751075.
287. Zhao, L.; Kim, T.-H.; Ahn, J.-C.; Kim, H.-W.; Kim, S.Y. Highly efficient “theranostics” system based on surface-modified gold nanocarriers for imaging and photodynamic therapy of cancer. J. Mater. Chem. B 2013, 42, 5806-5817.
288. Bauer, B.; Chen, S.; Käll, M.; Gunnarsson, L.; Ericson, M.B. Optical Interactions with Tissue and Cells XXII, In Metal Nanoparticles Amplify Photodynamic Effect on Skin Cells in Vitro. Proceedings of the SPIE, San Francisco, CA, USA, 22 January 2011; Jansen, E.D., Thomas, R.J., Eds.; p, 789712.
289. Cheng, Y.; Doane, T.L.; Chuang, C.H.; Ziady, A.; Burda, C. Near infrared light-triggered drug generation and release from gold nanoparticle carriers for photodynamic therapy. Small 2014, 10, 1799-1804.
290. Kuo, W.S.; Chang, Y.T.; Cho, K.C.; Chiu, K.C.; Lien, C.H.; Yeh, C.S.; Chen, S.J. Gold nanomaterials conjugated with indocyanine green for dual-modality photodynamic and photothermal therapy. Biomaterials 2012, 33, 3270-3278.
291. Wang, J.; Zhu, G.; You, M.; Song, E.; Shukoor, M.I.; Zhang, K.; Altman, M.B.; Chen, Y.; Zhu, Z.; Huang, C.Z.; et al. Assembly of Aptamer Switch Probes and Photosensitizer on Gold Nanorods for Targeted Photothermal and Photodynamic Cancer Therapy. ACS Nano 2012, 6, 5070-5077.
292. Zhao, T.; Yu, K.; Li, L.; Zhang, T.; Guan, Z.; Gao, N.; Yuan, P.; Li, S.; Yao, S.Q.; Xu, Q.H.; et al. Gold nanorod enhanced two-photon excitation fluorescence of photosensitizers for two-photon imaging and photodynamic therapy. Acs Appl. Mater. Int. 2014, 6, 2700-2708.
293. Chouikrat, R.; Seve, A.; Vanderesse, R.; Benachour, H.; Barberi-Heyob, M.; Richeter, S.; Raehm, L.; Durand, J.O.; Verelst, M.; Frochot, C. Non polymeric nanoparticles for photodynamic therapy applications: Recent developments. Curr. Med. Chem. 2012, 19, 781-792.
294. Hone, D.C.; Walker, P.I.; Evans-Gowing, R.; FitzGerald, S.; Beeby, A.; Chambrier, I.; Cook, M.J.; Russell, D.A. Generation of Cytotoxic Singlet Oxygen via Phthalocyanine-Stabilized Gold Nanoparticles: A Potential Delivery Vehicle for Photodynamic Therapy. Langmuir 2002, 18, 2985-2987.
295. Wieder, M.E.; Hone, D.C.; Cook, M.J.; Handsley, M.M.; Gavrilovic, J.; Russell, D.A. Intracellular photodynamic therapy with photosensitizer-nanoparticle conjugates: Cancer therapy using a “Trojan horse”. Photochem. Photobiol. Sci. 2006, 5, 727-734.
296. Liu, J.; Ohta, S.; Sonoda, A.; Yamada, M.; Yamamoto, M.; Nitta, N.; Murata, K.; Tabata, Y. Preparation of PEG-conjugated fullerene containing Gd3+ ions for photodynamic therapy. J. Control. Release 2007, 117, 104-110.
297. Madani, S.Y.; Naderi, N.; Dissanayake, O.; Tan, A.; Seifalian, A.M. A new era of cancer treatment: Carbon nanotubes as drug delivery tools. Int. J. Nanomed. 2011, 6, 2963-2979.
298. Wang, S.; Gao, R.; Zhou, F.; Selke, M. Nanomaterials and singlet oxygen photosensitizers: Potential applications in photodynamic therapy. J. Mater. Chem. 2004, 14, 487.
299. Huang, L.; Terakawa, M.; Zhiyentayev, T.; Huang, Y.Y.; Sawayama, Y.; Jahnke, A.; Tegos, G.P.; Wharton, T.; Hamblin, M.R. Innovative cationic fullerenes as broad-spectrum light-activated antimicrobials. Nanomed. Nanotechnol. Biol. Med. 2010, 6, 442-452.
300. Mroz, P.; Pawlak, A.; Satti, M.; Lee, H.; Wharton, T.; Gali, H.; Sarna, T.; Hamblin, M.R. Functionalized fullerenes mediate photodynamic killing of cancer cells: Type I versus Type II photochemical mechanism. Free Radic. Biol. Med. 2007, 43, 711-719.
301. Markovic, Z.; Trajkovic, V. Biomedical potential of the reactive oxygen species generation and quenching by fullerenes (C60). Biomaterials 2008, 29, 3561-3573.
302. Markovic, Z.; Todorovic-Markovic, B.; Kleut, D.; Nikolic, N.; Vranjes-Djuric, S.; Misirkic, M.; Vucicevic, L.; Janjetovic, K.; Isakovic, A.; Harhaji, L.; et al. The mechanism of cell-damaging reactive oxygen generation by colloidal fullerenes. Biomaterials 2007, 28, 5437-5448.
303. Yamakoshi, Y.; Umezawa, N.; Ryu, A.; Arakane, K.; Miyata, N.; Goda, Y.; Masumizu, T.; Nagano, T. Active oxygen species generated from photoexcited fullerene (C60) as potential medicines: O2−* versus 1O 2. J. Am. Chem. Soc. 2003, 125, 12803-12809.
304. Kam, N.W.S.; O’Connell, M.; Wisdom, J.A.; Dai, H. Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proc. Natl. Acad. Sci. USA 2005, 102, 11600-11605.
305. Erbas, S.; Gorgulu, A.; Kocakusakogullari, M.; Akkaya, E.U. Non-covalent functionalized SWNTs as delivery agents for novel Bodipy-based potential PDT sensitizers. Chem.Commun. 2009, 33, 4956-4958.
306. Chen, Y.; Qi, Y.; Liu, B. Polyacrylic Acid Functionalized Nanographene as a Nanocarrier for Loading and Controlled Release of Doxorubicin Hydrochloride. J. Nanomater. 2013, 2013, 1-8.
307. Liu, J.-H.; Wang, T.; Wang, H.; Gu, Y.; Xu, Y.; Tang, H.; Jia, G.; Liu, Y. Biocompatibility of graphene oxide intravenously administrated in mice—effects of dose, size and exposure protocols. Toxicol. Res. 2015, 4, 83-91.
308. Huang, P.; Xu, C.; Lin, J.; Wang, C.; Wang, X.; Zhang, C.; Zhou, X.; Guo, S.; Cui, D. Folic Acid-conjugated Graphene Oxide loaded with Photosensitizers for Targeting Photodynamic Therapy. Theranostics 2011, 1, 240-250.
309. Webber, J.; Herman, M.; Kessel, D.; Fromm, D. Current Concepts in Gastrointestinal Photodynamic Therapy. An. Surg. 1999, 230, 12.
310. Wiegell, S.R.; Wulf, H.C.; Szeimies, R.M.; Basset-Seguin, N.; Bissonnette, R.; Gerritsen, M.J.P.; Gilaberte, Y.; Calzavara-Pinton, P.; Morton, C.A.; Sidoroff, A.; et al. Daylight photodynamic therapy for actinic keratosis: An international consensus. J. Eur. Acad. Dermatol. Venereol. 2012, 26, 673-679.
311. Roberts, W.G.; Smith, K.M.; McCullough, J.L.; Berns, M.W. Skin photosensitivity and photodestruction of several potential photodynamic sensitizers. Photochem. Photobiol. 1989, 49, 431-438.
312. Ericson, M.B.; Wennberg, A.-M.; Larkö, O. Review of photodynamic therapy in actinic keratosis and basal cell carcinoma. Ther. Clin. Risk Manag. 2008, 4, 1-9.
313. Kapur, N.; Lang, K.K.; Braathen, L. Photodynamic therapy-induced pain: A patient centred survey. J. Am. Acad. Dermatol. 2004, 50, 136.
314. Kasche, A.; Luderschmidt, S.; Ring, J.; Hein, R. Photodynamic therapy induces less pain in patients treated with methyl aminolevulinate compared to aminolevulinic acid. J. Drug. Dermatol. JDD 2006, 5, 353-356.